Please try another search
For the three months ended 31 May 2019, US-ChinaBiomedical Technology Inc revenues was not reported. Netloss decreased 55% to $123K. Lower net loss reflects Losson settlement of debt decrease from $184K (expense) to $0K,Interest expense - related party decrease of 87% to $1K(expense). Basic Earnings per Share excluding ExtraordinaryItems increased from -$0.02 to -$0.01.
Period Ending: | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -0.12 | -0.17 | -0.12 | -0.14 |
Net Income | -0.12 | -0.17 | -0.12 | -0.14 |
Period Ending: | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 |
---|---|---|---|---|
Total Assets | 0.49 | 0.08 | 0.24 | 0.37 |
Total Liabilities | 0.39 | 0.08 | 0.06 | 0.08 |
Total Equity | 0.09 | 0 | 0.18 | 0.29 |
Period Ending: | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -0.11 | -0.54 | -0.37 | -0.24 |
Cash From Investing Activities | ||||
Cash From Financing Activities | 0.21 | 0.52 | 0.52 | 0.52 |
Net Change in Cash | 0.11 | -0.02 | 0.16 | 0.28 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review